anti human crth2 receptor antibody Search Results


90
Becton Dickinson anti-human crth2 pe-cf594 bm16

Anti Human Crth2 Pe Cf594 Bm16, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/crth2++bm16+antibody/pmc10213874-40-0-6
Average 90 stars, based on 1 article reviews
anti-human crth2 pe-cf594 bm16 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Miltenyi Biotec anti human crth2pe

Anti Human Crth2pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CD294+(CRTH2)+Antibody%2C+anti-human%2C+REAfinity/pm37680638-64-27-33
Average 93 stars, based on 1 article reviews
anti human crth2pe - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Miltenyi Biotec cd294 (crth2) antibody, anti-human

Cd294 (Crth2) Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CD294+(CRTH2)+Antibody%2C+anti-human/custom%40130-114-126%4034973310
Average 92 stars, based on 1 article reviews
cd294 (crth2) antibody, anti-human - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
ProSci Incorporated anti crth2 antibody

Anti Crth2 Antibody, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CRTH2+Antibody/pmc05736881-36-31-33
Average 92 stars, based on 1 article reviews
anti crth2 antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
fluidigm 3163003b

3163003b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/Anti-Human+CD294%2FCRTH2+(BM16)-163Dy/pmc09255966-23-11-8
Average 93 stars, based on 1 article reviews
3163003b - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Miltenyi Biotec biotin anti crth2 rea598

Biotin Anti Crth2 Rea598, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/Biotin+Antibody/pm29023707-4187-85-88
Average 96 stars, based on 1 article reviews
biotin anti crth2 rea598 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Charles River Laboratories monoclonal antibody against human crth2

Monoclonal Antibody Against Human Crth2, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/monoclonal+antibody+against+human+crth2/us10100120-578-2-27
Average 90 stars, based on 1 article reviews
monoclonal antibody against human crth2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
ProSci Incorporated crth2
The primer sequences used for amplification of <t> CRTH2. </t>
Crth2, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/PTGDR2+Peptide/pmc03511345-64-7-29
Average 93 stars, based on 1 article reviews
crth2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Miltenyi Biotec αcrth2 antibody coated microbeads
IL‐25R is highly expressed by in vitro differentiated <t>CRTh2</t> + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.
αcrth2 Antibody Coated Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CD294+(CRTH2)+MicroBead+Kit%2C+human/pmc04693727-68-3-9
Average 93 stars, based on 1 article reviews
αcrth2 antibody coated microbeads - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Bioss rabbit anti human crth2 polyclonal antibody
IL‐25R is highly expressed by in vitro differentiated <t>CRTh2</t> + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.
Rabbit Anti Human Crth2 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/GPR44+Polyclonal+Antibody/pm40445384-105-3-9
Average 94 stars, based on 1 article reviews
rabbit anti human crth2 polyclonal antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Novus Biologicals crth2 dp2
IL‐25R is highly expressed by in vitro differentiated <t>CRTh2</t> + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.
Crth2 Dp2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/DP2+Antibody/pmc05855778-132-37-38
Average 86 stars, based on 1 article reviews
crth2 dp2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
GeneTex rabbit anti-human crth2 polyclonal antibody
IL‐25R is highly expressed by in vitro differentiated <t>CRTh2</t> + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.
Rabbit Anti Human Crth2 Polyclonal Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+crth2+receptor+antibody/rabbit+anti+human+crth2+polyclonal+antibody/pm18802357-36-6-20
Average 90 stars, based on 1 article reviews
rabbit anti-human crth2 polyclonal antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell Reports Medicine

Article Title: The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis

doi: 10.1016/j.xcrm.2023.101038

Figure Lengend Snippet:

Article Snippet: anti-human CRTH2 PE-CF594 (Clone BM16) , BD , Cat#563501.

Techniques: Software, Staining

Journal: eLife

Article Title: Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV

doi: 10.7554/eLife.78870

Figure Lengend Snippet:

Article Snippet: Antibody , Anti-Human CD294/CRTH2 (BM16) (Rat, Monoclonal) , Fluidigm , Cat# 3163003B , CyTOF (1:50).

Techniques: Recombinant, Plasmid Preparation, Software

The primer sequences used for amplification of  CRTH2.

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: The primer sequences used for amplification of CRTH2.

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Amplification

The incubation conditions and the catalogue numbers for all antibodies used.

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: The incubation conditions and the catalogue numbers for all antibodies used.

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Incubation

mRNA was isolated from cultured amniocytes, myocytes, PBMCs, choriodecidual and placental extracts and converted to cDNA (n = 6). Qualitative PCR was used with three primer sets to amplify CRTH2 showing product sizes of 309 bp, 265 bp, and 114 bp. Non-template and reverse transcriptase negative controls were used and mRNA from placenta, choriodecidua and peripheral blood mononuclear cells were used as a positive controls. ( A , B ): Non-template control (lane 1), amniocytes (lane 2), choriodecidua (lane 3), myocytes (lane 4), placenta (lane 5); ( C ): Reverse transcriptase controls (lanes 1,3,5,7,9), PBMCs (lane 2), amniocytes (lanes 4,6), myocytes (lanes 8,10).

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: mRNA was isolated from cultured amniocytes, myocytes, PBMCs, choriodecidual and placental extracts and converted to cDNA (n = 6). Qualitative PCR was used with three primer sets to amplify CRTH2 showing product sizes of 309 bp, 265 bp, and 114 bp. Non-template and reverse transcriptase negative controls were used and mRNA from placenta, choriodecidua and peripheral blood mononuclear cells were used as a positive controls. ( A , B ): Non-template control (lane 1), amniocytes (lane 2), choriodecidua (lane 3), myocytes (lane 4), placenta (lane 5); ( C ): Reverse transcriptase controls (lanes 1,3,5,7,9), PBMCs (lane 2), amniocytes (lanes 4,6), myocytes (lanes 8,10).

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Isolation, Cell Culture, Reverse Transcription, Control

50 µg of whole cell lysate from PBMCs, amniocytes, myocytes were subject to western analysis. Membranes were probed with the primary antibody -SC-23092 to detect a Mr∼34 000 product ( A ; Lanes 1–3). The secondary antibody control blot is also shown ( B ; Lanes 1–3). β-actin was used as a loading control. Lane 1 = PBMCs, lane 2 = amniocytes, lane 3 = myocytes. Multiple bands are seen on the blot. A band appears at Mr∼34 000 in amniocytes, faintly in the myocyte lane, but is absent in the positive control PBMCs lane. However, the strongest bands appear at Mr∼15 000 and at just above Mr∼43 000 in all lanes. Myocytes from passage zero, one, two, three and four (lanes 1–5 respectively) were also examined for CRTH2 expression showing a very faint band at Mr∼34 000, with no effect of passage number ( C ).

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: 50 µg of whole cell lysate from PBMCs, amniocytes, myocytes were subject to western analysis. Membranes were probed with the primary antibody -SC-23092 to detect a Mr∼34 000 product ( A ; Lanes 1–3). The secondary antibody control blot is also shown ( B ; Lanes 1–3). β-actin was used as a loading control. Lane 1 = PBMCs, lane 2 = amniocytes, lane 3 = myocytes. Multiple bands are seen on the blot. A band appears at Mr∼34 000 in amniocytes, faintly in the myocyte lane, but is absent in the positive control PBMCs lane. However, the strongest bands appear at Mr∼15 000 and at just above Mr∼43 000 in all lanes. Myocytes from passage zero, one, two, three and four (lanes 1–5 respectively) were also examined for CRTH2 expression showing a very faint band at Mr∼34 000, with no effect of passage number ( C ).

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Western Blot, Control, Positive Control, Expressing

The in vitro transcription translation kit was used with 35 S Methionine to demonstrate the expression of CRTH2 and to provide a positive control for detection of CRTH2. A Mr∼34 000 product was detected by x-ray (Lane 2). The progesterone expression vector was used as a control for the TNT kit ( A ). The protein lysate from the TNT kit was subjected to western analysis; Negative Control: TNT kit with no plasmid DNA (lane 1), Negative control: Progesterone PSG5 Expression vector (lane 2), Positive control: 35 S Methionine labelled CRTH2 (Lane 3), Cold Methionine CRTH2 protein product (lane 4). Membranes were probed with 3 commercial antibodies; SC-23092 ( B ), SC-21798 ( C ), ProSci 4027 ( D ). None of the antibodies detected CRTH2.

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: The in vitro transcription translation kit was used with 35 S Methionine to demonstrate the expression of CRTH2 and to provide a positive control for detection of CRTH2. A Mr∼34 000 product was detected by x-ray (Lane 2). The progesterone expression vector was used as a control for the TNT kit ( A ). The protein lysate from the TNT kit was subjected to western analysis; Negative Control: TNT kit with no plasmid DNA (lane 1), Negative control: Progesterone PSG5 Expression vector (lane 2), Positive control: 35 S Methionine labelled CRTH2 (Lane 3), Cold Methionine CRTH2 protein product (lane 4). Membranes were probed with 3 commercial antibodies; SC-23092 ( B ), SC-21798 ( C ), ProSci 4027 ( D ). None of the antibodies detected CRTH2.

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: In Vitro, Expressing, Positive Control, Plasmid Preparation, Control, Western Blot, Negative Control

Lymphocytes were gated according to forward scatter and side scatter and T helper cells were identified using CD4 as a cell surface marker (n = 6). A representative cytogram is presented with the right upper quadrant showing CRTH2 + /CD4 + lymphocytes ( A ). Histograms showing no staining, isotype control and CRTH2 + labelled lymphocytes ( B ), amniocytes ( C ) and myocytes ( D ), (n = 5).

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: Lymphocytes were gated according to forward scatter and side scatter and T helper cells were identified using CD4 as a cell surface marker (n = 6). A representative cytogram is presented with the right upper quadrant showing CRTH2 + /CD4 + lymphocytes ( A ). Histograms showing no staining, isotype control and CRTH2 + labelled lymphocytes ( B ), amniocytes ( C ) and myocytes ( D ), (n = 5).

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Marker, Staining, Control

An overview of the mean fluorescence intensities and percentages in the gated cells during detection of endogenous  CRTH2  in lymphocytes, amniocytes and myocytes.

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: An overview of the mean fluorescence intensities and percentages in the gated cells during detection of endogenous CRTH2 in lymphocytes, amniocytes and myocytes.

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Fluorescence

Amniocytes ( A ) and myocytes ( B ) were transfected using gene juice and electroporation respectively with CRTH2 PSG5 expression vector and labeled with anti-CRTH2-PE. A small shift to the right is seen in the histogram showing expression of CRTH2 in transfected cells with an increase in the mean fluorescence intensity from 87.75 in the isotype control to 143.49 in amniocytes, and from 68.84 to 96.97 in myocytes. An example of a GFP control is given for the myocyte transfection, with cells imaged with phase contrast and with the fluorescent microscope to detect GFP transfected cells ( C ). A direct comparison is also shown with non-GFP transfected cells ( D ).

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: Amniocytes ( A ) and myocytes ( B ) were transfected using gene juice and electroporation respectively with CRTH2 PSG5 expression vector and labeled with anti-CRTH2-PE. A small shift to the right is seen in the histogram showing expression of CRTH2 in transfected cells with an increase in the mean fluorescence intensity from 87.75 in the isotype control to 143.49 in amniocytes, and from 68.84 to 96.97 in myocytes. An example of a GFP control is given for the myocyte transfection, with cells imaged with phase contrast and with the fluorescent microscope to detect GFP transfected cells ( C ). A direct comparison is also shown with non-GFP transfected cells ( D ).

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Transfection, Electroporation, Expressing, Plasmid Preparation, Labeling, Fluorescence, Control, Microscopy, Comparison

An overview of the mean fluorescence intensities and percentages in the gated cells during detection of transfected  CRTH2  in amniocytes and myocytes.

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: An overview of the mean fluorescence intensities and percentages in the gated cells during detection of transfected CRTH2 in amniocytes and myocytes.

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Fluorescence, Transfection

PBMCs were treated with 32 µM of 15dPGJ2 for 2 hours with or without preincubation with 2 µM of GSKCRTH2X for 45 mins. Whole cell protein lysate was examined for levels of phosphorylated p65 (p-p65) using immunoblotting. A representative immunoblot from n = 6 samples are shown ( A ). Immunoblots were reprobed for β-actin as an internal loading control. Densitometric analysis of the immunoblots was conducted revealing a complete inhibition of p-p65 levels with 15dPGJ2. Pre-incubation with the CRTH2 antagonist GSKCRTH2X had no effect on inhibition ( B ). J2 = 15dPGJ2, GSKX = GSKCRTH2X. Effect of treatment was examined for statistical significance using ANOVA of repeated measures with Bonferroni’s multiple comparison test; **** P <0.0001.

Journal: PLoS ONE

Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

doi: 10.1371/journal.pone.0050734

Figure Lengend Snippet: PBMCs were treated with 32 µM of 15dPGJ2 for 2 hours with or without preincubation with 2 µM of GSKCRTH2X for 45 mins. Whole cell protein lysate was examined for levels of phosphorylated p65 (p-p65) using immunoblotting. A representative immunoblot from n = 6 samples are shown ( A ). Immunoblots were reprobed for β-actin as an internal loading control. Densitometric analysis of the immunoblots was conducted revealing a complete inhibition of p-p65 levels with 15dPGJ2. Pre-incubation with the CRTH2 antagonist GSKCRTH2X had no effect on inhibition ( B ). J2 = 15dPGJ2, GSKX = GSKCRTH2X. Effect of treatment was examined for statistical significance using ANOVA of repeated measures with Bonferroni’s multiple comparison test; **** P <0.0001.

Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and CRTH2 for western analysis were purchased from Cell Signaling Technology (Beverly, MA), Santa Cruz Biotechnology (Santa Cruz, CA) or Santa Cruz and ProSci Incorporated (Poway, CA) respectively.

Techniques: Western Blot, Control, Inhibition, Incubation, Comparison

IL‐25R is highly expressed by in vitro differentiated CRTh2 + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor

doi: 10.1002/iid3.87

Figure Lengend Snippet: IL‐25R is highly expressed by in vitro differentiated CRTh2 + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.

Article Snippet: On day 14, αCRTh2 antibody coated microbeads (Cat. #130‐091‐274, Miltenyi) were used to isolate CRTh2‐expressing cells.

Techniques: In Vitro, Flow Cytometry, Control, Quantitative RT-PCR, Expressing, Activation Assay

IL‐25 mediates acquisition of the Th2 phenotype. Naïve CD4 + T cells were differentiated in non‐polarizing (NP) control conditions (αCD3/αCD28, IL‐2, αIFNγ and αIL‐12) or NP + IL‐4 (IL‐4), NP + IL‐25 (IL‐25) or NP + IL‐4 and IL‐25 (IL‐4+IL‐25). (A) IL‐25R mRNA expression (fold increase over NP; day 3, 7, 10, 14, n = 10 of three independently differentiated lines). (B) Intracellular IL‐4 and (E) surface CRTh2 were assayed following proliferation (day 7, 14, n = 17, 10 independently differentiated lines). (D) GATA3 was assayed after stimulation (day 3, 10, n = 17, 10 independently differentiated lines). (C) IL‐4 mRNA expression by cells cultured in IL‐4 or IL‐25 (fold increase over NP, day 14; n = 4 independently differentiated lines). (F) Cell counts were determined and comparison was made between the four conditions for each day. Statistical significance determined by repeated measures ANOVA, * P < 0.05.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor

doi: 10.1002/iid3.87

Figure Lengend Snippet: IL‐25 mediates acquisition of the Th2 phenotype. Naïve CD4 + T cells were differentiated in non‐polarizing (NP) control conditions (αCD3/αCD28, IL‐2, αIFNγ and αIL‐12) or NP + IL‐4 (IL‐4), NP + IL‐25 (IL‐25) or NP + IL‐4 and IL‐25 (IL‐4+IL‐25). (A) IL‐25R mRNA expression (fold increase over NP; day 3, 7, 10, 14, n = 10 of three independently differentiated lines). (B) Intracellular IL‐4 and (E) surface CRTh2 were assayed following proliferation (day 7, 14, n = 17, 10 independently differentiated lines). (D) GATA3 was assayed after stimulation (day 3, 10, n = 17, 10 independently differentiated lines). (C) IL‐4 mRNA expression by cells cultured in IL‐4 or IL‐25 (fold increase over NP, day 14; n = 4 independently differentiated lines). (F) Cell counts were determined and comparison was made between the four conditions for each day. Statistical significance determined by repeated measures ANOVA, * P < 0.05.

Article Snippet: On day 14, αCRTh2 antibody coated microbeads (Cat. #130‐091‐274, Miltenyi) were used to isolate CRTh2‐expressing cells.

Techniques: Control, Expressing, Cell Culture, Comparison

Regulation of IL‐25R on Th2 cells. Differentiated CRTh2 + Th2 cells were cultured with IL‐2 in the presence or absence of IL‐25 and stained for (A) IL‐25R ( n = 5, three independently differentiated cell lines) or assessed for (B) IL‐25R mRNA levels ( n = 3). (C) Surface expression of IL‐25R on CRTh2 + Th2 cells treated (24 h) with a CRTh2 agonist (DK‐PGD 2 ) or IL‐2 ( n = 4). Statistical significance determined by paired t test within each time point (A, B) or between conditions (C), * P < 0.05.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor

doi: 10.1002/iid3.87

Figure Lengend Snippet: Regulation of IL‐25R on Th2 cells. Differentiated CRTh2 + Th2 cells were cultured with IL‐2 in the presence or absence of IL‐25 and stained for (A) IL‐25R ( n = 5, three independently differentiated cell lines) or assessed for (B) IL‐25R mRNA levels ( n = 3). (C) Surface expression of IL‐25R on CRTh2 + Th2 cells treated (24 h) with a CRTh2 agonist (DK‐PGD 2 ) or IL‐2 ( n = 4). Statistical significance determined by paired t test within each time point (A, B) or between conditions (C), * P < 0.05.

Article Snippet: On day 14, αCRTh2 antibody coated microbeads (Cat. #130‐091‐274, Miltenyi) were used to isolate CRTh2‐expressing cells.

Techniques: Cell Culture, Staining, Expressing

IL‐25 slows re‐expression of CRTh2 on Th2 cells following TCR activation. (A) Differentiated CRTh2 + Th2 cells cultured with IL‐2, αCD3 and αCD28 exhibited time dependent loss of surface CRTh2 expression ( n = 4, two independently differentiated cell lines). (B–G) CRTh2 + Th2 cells were cultured with IL‐2, αCD3 and αCD28 (24 h) and then placed with IL‐2 in the presence or absence of IL‐25 (another 24 h). % of cells expressing (B) CRTh2, (D) CD62L or (F) CCR4 and mean fluorescent intensity (MFI) for (C) CRTh2, (E) CD62L and (G) CCR4 were quantified ( n = 6, two independently differentiated lines). Statistical significance was determined by paired t test (B–G), * P < 0.05.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor

doi: 10.1002/iid3.87

Figure Lengend Snippet: IL‐25 slows re‐expression of CRTh2 on Th2 cells following TCR activation. (A) Differentiated CRTh2 + Th2 cells cultured with IL‐2, αCD3 and αCD28 exhibited time dependent loss of surface CRTh2 expression ( n = 4, two independently differentiated cell lines). (B–G) CRTh2 + Th2 cells were cultured with IL‐2, αCD3 and αCD28 (24 h) and then placed with IL‐2 in the presence or absence of IL‐25 (another 24 h). % of cells expressing (B) CRTh2, (D) CD62L or (F) CCR4 and mean fluorescent intensity (MFI) for (C) CRTh2, (E) CD62L and (G) CCR4 were quantified ( n = 6, two independently differentiated lines). Statistical significance was determined by paired t test (B–G), * P < 0.05.

Article Snippet: On day 14, αCRTh2 antibody coated microbeads (Cat. #130‐091‐274, Miltenyi) were used to isolate CRTh2‐expressing cells.

Techniques: Expressing, Activation Assay, Cell Culture